The Beacon Consulting Difference
Proprietary Beacon data,
powered by the experts behind it
No one understands Beacon’s data, methodologies and ontologies better than the experts who help shape them. We uncover insights that would otherwise remain hidden in complex datasets
Direct Access to
Market Voices
Access insights from KOLs, industry leaders, researchers and clinicians who influence drug development strategy, manufacturing and prescribing behaviour, though our extensive life science network.
Scientific Expertise that Translates into
Business Action
Our consultants combine scientific training with commercial strategy expertise, ensuring complex evidence is transformed into clear, actionable recommendations.
Life science sectors Beacon Consulting supports
Pharma and biotech companies
Supporting portfolio strategy, clinical development, competitive intelligence, licensing and acquisition decisions and commercialization planning, allowing pharma to drive commercial success.
Emerging Biotech & Startups
Helping leadership teams de-risk development decisions, sharpen investor narratives and support fundraising activities.
Service providers (CDMOs, CROs, diagnostics & technology providers)
Informing product strategy, commercial positioning, business development and market expansion decisions.
Investors & Advisory Firms
Delivering investment-grade market intelligence to support commercial due diligence, asset assessment, valuation, deal sourcing and investment decision-making
Strategic Intelligence for Better Decisions
Investment-grade market intelligence powered by proprietary Beacon data, scientific expertise, and bespoke research to help life science organisations make faster, more confident decisions across the drug development lifecycle.
Supporting Decision-Makers Across the Organisation
Beacon Consulting supports stakeholders across the organisation, providing the intelligence needed to inform high-impact decisions from pipeline strategy through to post-launch.
- Commercial & Marketing
- Competitive Intelligence
- Corporate Strategy & Insights
- Preclinical Development
- Clinical Development
- Business Development & Licensing
- Portfolio Management
- Research & Development
- Executive Leadership
Scientific & Commercial Expertise Across the Drug Dev Lifecycle
Deep Expertise in Preclinical and Early Development Intelligence
Beacon Consulting combines industry-leading preclinical and clinical data with scientific and commercial expertise to answer complex questions across the drug development lifecycle.
Our research can be tailored to your specific needs, including:
- Drug assets
- Modalities
- Disease areas
- Development stage
- Organisation type
- Technologies and services
- Commercial strategy
Why Clients Work with Beacon Consulting
Beacon Consulting helps life science organisations make faster, more confident decisions through investment-grade market intelligence powered by proprietary Beacon data, scientific expertise, and bespoke market research.
- Gain unique insight from the proprietary Beacon database
- Turn complex data into clear strategic recommendations
- Make faster, evidence-based decisions
- Reduce development, commercial and investment risk
- Identify opportunities before competitors
- Access specialist expertise without increasing headcount
Explore Our Latest Content
Beacon Consulting provides bespoke market research and consultancy that can elevate and go beyond Beacon data…
…Beacon Consulting transforms data into insights allowing our clients to make more informed and better strategic business decisions, decreasing risk and increasing the chances of success
Empower Your Drug Development with Cutting-Edge Data Solutions
ADC
Autoimmune
Bispecific
Cancer Vaccine
Cell Therapy
Checkpoint
CVRM
Cytokine
DDR
Gene Therapy
Microbiome
Neurology
Neuroscience
Oncology
Oncolytic Viruses
Psychiatric
RNA
TPD
Beacon ADC
Complete transparency into the ADC drug development landscape
- Unrivalled comprehensive & accurate preclinical & clinical ADC drug, trial and commercial data
- Access to 3,800+ Drugs, 4,300+ Trials, 2,500+ Companies, and 3,000+ Deals in the ADC space
- Market leading ontologies, enabling precise navigation of specific ADC technologies
- Manually curated by ADC scientists, with data updated daily
Beacon Autoimmune
Complete transparency into the Autoimmune drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Autoimmune drug, trial and commercial data
- Access to 7,000+ Drugs, 14,500+ Trials, 7,200+ Companies, and 9,200+ Deals in the Autoimmune space
- Market leading ontologies, enabling precise navigation of specific Autoimmune therapies
- Manually curated by Autoimmune scientists, with data updated daily
Beacon Bispecific
Complete transparency into the Bispecific drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Bispecific therapeutic drug, trial and commercial data
- Access to 3,500+ Drugs, 3,200+ Trials, 2,400+ Companies, and 2,800+ Deals in the Bispecific space
- Market leading ontologies, enabling precise navigation of specific Bispecifics
- Manually curated by Bispecific scientists, with data updated daily
Beacon Cancer Vaccine
Complete transparency into the Cancer Vaccine development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cancer Vaccine drug, trial and commercial data
- Access to 1,800+ Drugs, 1,800+ Trials, 1,600+ Companies, and 1,800+ Deals in the Cancer Vaccine space
- Market leading ontologies, enabling precise navigation of specific Cancer Vaccines
- Manually curated by Cancer Vaccine scientists, with data updated daily
Beacon Cell Therapy
Complete transparency into the Cell Therapy development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cell Therapy drug, trial and commercial data
- Access to 8,100+ Drugs, 6,500+ Trials, 3,700+ Companies, and 4,700+ Deals in the Cell Therapy space
- Market leading ontologies, enabling precise navigation of specific Cell Therapies
- Manually curated by Cell Therapy scientists, with data updated daily
Beacon Checkpoint
Complete transparency into the Checkpoint drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Checkpoint drug, trial and commercial data
- Access to 2,500+ Drugs, 16,600+ Trials, 2,500+ Companies, and 3,300+ Deals in the Checkpoint space
- Market leading ontologies, enabling precise navigation of specific Checkpoint therapeutics
- Manually curated by Checkpoint scientists, with data updated daily
Beacon CVRM
Complete transparency into the CVRM drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical CVRM drug, trial and commercial data
- Access to 5,000+ Drugs, 16,500+ Trials, 3,000+ Companies, and 3,000+ Deals in the CVRM space
- Market leading ontologies, enabling precise navigation of the CVRM drug development landscape
- Manually curated by CVRM scientists, with data updated daily
Beacon Cytokine
Complete transparency into the Cytokine drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cytokine drug, trial and commercial data
- Access to 3,500+ Drugs, 11,200+ Trials, 3,700+ Companies, and 4,300+ Deals in the Cytokine space
- Market leading ontologies, enabling precise navigation of specific Cytokine targeting therapies
- Manually curated by Cytokine scientists, with data updated daily
Beacon DDR
Complete transparency into the DDR drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical DDR drug, trial and commercial data
- Access to 900+ Drugs, 2,100+ Trials, 1,100+ Companies, and 1,100+ Deals in the DDR space
- Market leading ontologies, enabling precise navigation of the DDR drug development landscape
- Manually curated by DDR scientists, with data updated daily
Beacon Gene Therapy
Complete transparency into the Gene Therapy drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Gene Therapy drug, trial and commercial data
- Access to 2,800+ Drugs, 1,300+ Trials, 2,000+ Companies, and 2,300+ Deals in the Gene Therapy space
- Market leading ontologies, enabling precise navigation of specific Gene Therapies
- Manually curated by Gene Therapy scientists, with data updated daily
Beacon Microbiome
Complete transparency into the Microbiome drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Microbiome drug, trial and commercial data
- Access to 1,300+ Drugs, 1,200+ Trials, 1,100+ Companies, and 900+ Deals in the Microbiome space
- Market leading ontologies, enabling precise navigation of the Microbiome drug development landscape
- Manually curated by Microbiome scientists, with data updated daily
Beacon Neurology
Complete transparency into the Neurology drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Neurology drug, trial and commercial data
- Access to 7,600+ Drugs and 9,100+ Trials, 5,600+ Companies, and 4,700+ Deals in the Neurology space since 2011
- Market leading ontologies, enabling precise navigation of the Neurology drug development landscape
- Manually curated by Neurology scientists, with data updated daily
Beacon Neuroscience
Complete transparency into the Neuroscience drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Neuroscience drug, trial and commercial data
- Access to 9,000+ Drugs, 14,000+ Trials, 5,600+ Companies, and 4,700+ Deals in the Neuroscience space since 2011
- Market leading ontologies, enabling precise navigation of the Neuroscience drug development landscape
- Manually curated by Neuroscience scientists, with data updated daily
Beacon Oncology
Complete transparency into the Oncology drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Oncology drug, trial and commercial data
- Access to 28,000+ Drugs, 54,000+ Trials, 9,400+ Companies, and 16,300+ Deals in the Oncology space
- Market leading ontologies, enabling precise navigation of the Oncology drug development landscape
- Manually curated by Oncology scientists, with data updated daily
Beacon Oncolytic Viruses
Complete transparency into the Oncolytic Viruses drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Oncolytic Virus drug, trial and commercial data
- Access to 750+ Drugs, 650+ Trials, 650+ Companies, and 650+ Deals in the Oncolytic Virus space
- Market leading ontologies, enabling precise navigation of specific Oncolytic Virus’
- Manually curated by Oncolytic Virus scientists, with data updated daily
Beacon Psychiatric
Complete transparency into the Psychiatric drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Psychiatric drug and trial data
- Access to 1,700+ Drugs and 5,200+ Trials in the Psychiatric space since 2011
- Market leading ontologies, enabling precise navigation of the Psychiatric drug development landscape
- Manually curated by Psychiatric scientists, with data updated daily
Beacon RNA
Complete transparency into the RNA drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical RNA therapeutic drug, trial and commercial data
- Access to 5,800+ Drugs, 2,700+ Trials, 3,400+ Companies, and 4,100+ Deals in the RNA Therapeutic space
- Market leading ontologies, enabling precise navigation of specific RNA therapeutics
- Manually curated by RNA scientists, with data updated daily
Beacon TPD
Complete transparency into the TPD drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical TPD drug, trial and commercial data
- Access to 2,400+ Drugs, 4,466+ Trials, 1,600+ Companies, and 1,500+ Deals in the TPD space
- Market leading ontologies, enabling precise navigation of the TPD drug development landscape
- Manually curated by TPD scientists, with data updated daily
Search